+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroendocrine Carcinoma"

Insulinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Insulinoma Treatment - Global Strategic Business Report

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
Pheochromocytoma Market Report 2025 - Product Thumbnail Image

Pheochromocytoma Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Esophageal Cancer Market Report 2025 - Product Thumbnail Image

Esophageal Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Somatostatin Analogs Market Report 2025 - Product Thumbnail Image

Somatostatin Analogs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • February 2025
  • 150 Pages
  • Global
From
Radioligand Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Radioligand Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 185 Pages
  • Global
From
Somatostatin Analogs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Somatostatin Analogs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 180 Pages
  • Global
From
Angiopoietin 1 Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Angiopoietin 1 Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 102 Pages
  • Global
From
Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022 - Product Thumbnail Image

Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022

  • Report
  • February 2018
  • 160 Pages
  • Global
From
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions - Product Thumbnail Image

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

  • Report
  • December 2018
  • 288 Pages
  • Global
From
Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031

  • Report
  • March 2022
  • 182 Pages
  • Global
From
Peptide Drug Conjugates Market Size, Share & Trends Analysis Report by Product (Illuccix, Pluvicto, CBX-12, Pipeline Products), Type (Diagnostic, Therapeutic), and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Peptide Drug Conjugates Market Size, Share & Trends Analysis Report by Product (Illuccix, Pluvicto, CBX-12, Pipeline Products), Type (Diagnostic, Therapeutic), and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 100 Pages
  • Global
From
Loading Indicator

Neuroendocrine carcinoma (NEC) is a rare type of cancer that affects the neuroendocrine system, which is responsible for the production of hormones. It is a type of cancer that is often difficult to diagnose and treat. Treatment options for NEC include surgery, chemotherapy, radiation therapy, and targeted therapies. Oncology drugs are used to treat NEC, and they can be used alone or in combination with other treatments. These drugs can help to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of recurrence. The Neuroendocrine Carcinoma market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of NEC, the development of new treatments, and the increasing availability of targeted therapies. Companies in the market include Novartis, Pfizer, Merck, AstraZeneca, and Roche. Show Less Read more